by Stacey Johnson | Jun 10, 2016
In 2002, Jennifer Molson received a stem cell transplant for her aggressive form of multiple sclerosis (MS), diagnosed six years earlier when she was 21. This unique treatment for MS – transplanting blood stem cells from a patient’s own bone marrow to replace the...
by Samantha Payne | Jun 7, 2016
The World Biomaterials Congress (WBC), which takes place once every four years, happened last month. Among the many excellent presentations at WBC, two themes related to cell-based therapies stood out: 1) the use of biomaterials to study cell behaviour and...
by Stacey Johnson | Jun 3, 2016
Have you ever wanted to shed your skin? I don’t mean in the metaphorical sense like becoming a different person, free of all the old baggage we accumulate in life. And I’m not talking about CCRM’s new logo and colours either, but thanks for noticing. (Shameless.) I...
by Paul Krzyzanowski | May 25, 2016
A few weeks ago, I came across an interesting story about a stem cell company with a peculiar patenting strategy. As I looked into it further, I realized I’d stumbled into a complicated corporate plot that became more incredible with every turn. Endonovo Therapeutics...
by Nick Dragojlovic | May 3, 2016
A growing focus of biomedical research and regenerative medicine is the effort to target the aging process itself, by either slowing or reversing the accumulation of cellular and molecular damage that drives age-related functional decline. The goal is to develop new...
Comments